Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Zignol

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Cancer|July 27, 2004
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyMatteo Zignol, Marta Peracchi, Gloria Tridello, et al.
Plos Medicine|February 28, 2020
Advances in clinical trial design: Weaving tomorrow's TB treatmentsChristian Lienhardt, Andrew Nunn, Richard Chaisson, et al.
Emerging Infectious Diseases|April 30, 2013
Multidrug-resistant tuberculosis, Somalia, 2010-2011Ireneaus Sindani, Christopher Fitzpatrick, Dennis Falzon, et al.
Scandinavian Journal of Infectious Diseases|April 4, 2002
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 casesDino Sgarabotto, Riccardo Cusinato, Elena Narne, et al.
The European Respiratory Journal|November 27, 2020
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 updateFuad Mirzayev, Kerri Viney, Nguyen Nhat Linh, et al.
Bulletin of the World Health Organization|June 27, 2006
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from IndiaKatherine Floyd, V K Arora, K J R Murthy, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 18, 2014
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance dataMatteo Zignol, Masoud Dara, Anna S Dean, et al.
Lancet (London, England)|May 22, 2010
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisNeel R Gandhi, Paul Nunn, Keertan Dheda, et al.
The European Respiratory Journal|October 19, 2011
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in MinskAlena Skrahina, Henadz Hurevich, Aksana Zalutskaya, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2003
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosisGyanu Lamichhane, Matteo Zignol, Natalie J Blades, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Cancer|July 27, 2004
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyMatteo Zignol, Marta Peracchi, Gloria Tridello, et al.
Plos Medicine|February 28, 2020
Advances in clinical trial design: Weaving tomorrow's TB treatmentsChristian Lienhardt, Andrew Nunn, Richard Chaisson, et al.
Emerging Infectious Diseases|April 30, 2013
Multidrug-resistant tuberculosis, Somalia, 2010-2011Ireneaus Sindani, Christopher Fitzpatrick, Dennis Falzon, et al.
Scandinavian Journal of Infectious Diseases|April 4, 2002
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 casesDino Sgarabotto, Riccardo Cusinato, Elena Narne, et al.
The European Respiratory Journal|November 27, 2020
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 updateFuad Mirzayev, Kerri Viney, Nguyen Nhat Linh, et al.
Bulletin of the World Health Organization|June 27, 2006
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from IndiaKatherine Floyd, V K Arora, K J R Murthy, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 18, 2014
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance dataMatteo Zignol, Masoud Dara, Anna S Dean, et al.
Lancet (London, England)|May 22, 2010
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisNeel R Gandhi, Paul Nunn, Keertan Dheda, et al.
The European Respiratory Journal|October 19, 2011
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in MinskAlena Skrahina, Henadz Hurevich, Aksana Zalutskaya, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2003
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosisGyanu Lamichhane, Matteo Zignol, Natalie J Blades, et al.
Pageof 9